Home > Annual Financials > VALIANT LABORATORIES

VALIANT LABORATORIES Financial Statement Analysis
[BOM: 543998|NSE : VALIANTLAB]

The Revenues of VALIANT LABORATORIES have decreased by -45.48% YoY .
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by -99.21 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

VALIANT LABORATORIES Last 5 Annual Financial Results
[BOM: 543998|NSE : VALIANTLAB]

ConsolidatedMar2024
Mar2023
Revenues ₹182 Cr₹334 Cr
Expenses ₹190 Cr₹299 Cr
Operating Profit (Excl OI) ₹-8.41 Cr₹35 Cr
Other Income ₹9.68 Cr₹4.89 Cr
Interest ₹0.08 Cr₹0.25 Cr
Depreciation ₹1.97 Cr₹1.56 Cr
Profit Before Tax ₹-0.77 Cr₹38 Cr
Profit After Tax ₹0.32 Cr₹29 Cr
Consolidated Net Profit ₹0.32 Cr₹29 Cr
Earnings Per Share (Rs)₹0.07₹8.91
PAT Margin (%)0.188.68
ROE(%)0.1928.86
ROCE(%)-0.2924.01
Total Debt/Equity(x)0.320.59

Key Financials

Market Cap : ₹ 462.8 Cr
Revenue (TTM) : ₹ 106.2 Cr
Net Profit(TTM) : ₹ -4.1 Cr
EPS (TTM) : ₹ -1.0
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
VALIANT LABORATORIES 8.2% -2.5% -44.8%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -2.1% 16.5%
CIPLA 3.6% 0.2% 2.3%
DR REDDYS LABORATORIES 3% -8.4% 0%
ZYDUS LIFESCIENCES 3.2% -1% 27.4%
DIVIS LABORATORIES 4.3% 6.5% 63.9%
MANKIND PHARMA -2.5% -8% 16.5%
TORRENT PHARMACEUTICALS 2.9% -0.5% 19.4%
LUPIN 8.2% 0.4% 37%


VALIANT LABORATORIES Revenues
[BOM: 543998|NSE : VALIANTLAB]

Y-o-Y

-45.48 %

5 Yr CAGR

-45.48 %

Years Revenues % Change
Mar2024 ₹182 Cr
-45.48
Mar2023 ₹334 Cr -


VALIANT LABORATORIES Operating Profit
[BOM: 543998|NSE : VALIANTLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2024 ₹-8.41 Cr
Negative
Mar2023 ₹35 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2024 -4.62%
Negative
Mar2023 10.5% -

VALIANT LABORATORIES Profit After Tax
[BOM: 543998|NSE : VALIANTLAB]

Y-o-Y

-98.90 %

5 Yr CAGR

-98.90 %

Years Profit After Tax % Change
Mar2024 ₹0.32 Cr
-98.90
Mar2023 ₹29 Cr -

PAT Margins
Y-o-Y

-97.93 %

5 Yr CAGR

-97.93 %

Years PAT Margin(%) % Change
Mar2024 0.18 %
-97.93
Mar2023 8.68 % -

VALIANT LABORATORIES Earnings Per Share (EPS)
[BOM: 543998|NSE : VALIANTLAB]

Y-o-Y

-99.21 %

5 Yr CAGR

-99.21 %

Years EPS % Change
Mar2024 ₹0.07
-99.21
Mar2023 ₹8.91 -

VALIANT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 543998|NSE : VALIANTLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2024 -0.29%
Negative
Mar2023 24.01% -

VALIANT LABORATORIES Share Price vs Sensex

Current Share Price : ₹106.4
Current MarketCap: ₹ 462.8 Cr
Updated EOD on :Feb 07,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

8.2%

-2.5%

-44.8%

SENSEX

0.5%

0.3%

7.9%

VALIANT LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about VALIANT LABORATORIES Financials


How the annual revenues of VALIANT LABORATORIES have changed ?

The Revenues of VALIANT LABORATORIES have decreased by -45.48% YoY .

How the Earnings per Share (EPS) of VALIANT LABORATORIES have changed?

The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by -99.21 % YoY .